Evidence map›Paper›PMID 25270275›Full record

Trial reportThe New England journal of medicine2014

Lower versus higher hemoglobin threshold for transfusion in septic shock.

Lars B Holst, Nicolai Haase, Jørn Wetterslev, Jan Wernerman, Anne B Guttormsen, Sari Karlsson, Pär I Johansson, Anders Aneman, Marianne L Vang, Robert Winding and 34 more

3 registry-linked trialsAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in The New England journal of medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 319 papers, 18 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
319citing papers in PubMed, 18 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01485315 phase3completednot on this map

Effects of Red Blood Cell Transfusion on Mortality and Morbidity in Patients With Septic Shock

TypeinterventionalSponsorScandinavian Critical Care Trials GroupRan2011 to 2014Enrolled1,005ConditionsSeptic ShockArmsSAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion
NCT03137446 nacompletednot on this mapstarted 2017, after this paper: background citation

Assessing Targeted Fluid Resuscitation Strategies Among Patients With Severe Sepsis and Septic Shock

TypeinterventionalSponsorRhode Island HospitalRan2017 to 2018Enrolled113ConditionsSeptic Shock, Severe SepsisArmsIntravenous Fluid Cap
NCT04859855 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Transfusional Trigger in Post-operative Oncologic Patients in Critical Care

TypeinterventionalSponsorAC Camargo Cancer CenterRan2021 to 2022Enrolled840ConditionsTransfusion, Oncology, Critical Care, SurgeryArmsRestrictive transfusional strategy, Liberal transfusional strategy
3 · Its place in the literature

Who cites it

319 citing papers in PubMed, 18 syntheses or guidelines pooled it.

  1. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Guideline
  2. Guideline
  3. Guideline
  4. Prophylactic red blood cell transfusions in children and neonates with cancer: An evidence-based clinical practice guideline.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Guideline
  5. Prophylactic Transfusion Strategies in Children Supported by Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2024
    Pooled it
  6. Pooled it
  7. Transfusion thresholds for guiding red blood cell transfusion.The Cochrane database of systematic reviews · 2021
    Pooled it
  8. Pooled it
  9. [S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2020
    Guideline
  10. Guideline
  11. Pooled it
  12. Guideline
  13. Pooled it
  14. Pooled it
  15. Recommendations on RBC Transfusion in General Critically Ill Children Based on Hemoglobin and/or Physiologic Thresholds From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2018
    Guideline
  16. Recommendations on RBC Transfusion in Infants and Children With Acquired and Congenital Heart Disease From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2018
    Guideline
  17. Pooled it
  18. Pooled it
  19. Trial
  20. Trial

259 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors.

Lars B HolstFrom the Department of Intensive Care (L.B.H., N.H., L.H.A., U.G.P., N.R., J. Wiis, J.O.W., L.R., K.J.T., P.B.H., R.G.M., M.H.M., M.S., A.P.), Copenhagen Trial Unit, Center for Clinical Intervention Research (J. Wetterslev, P.W.), and Section for Transfusion Medicine (P.I.J.), Rigshospitalet and University of Copenhagen, Copenhagen, Randers Hospital, Randers (M.L.V., H.B., M.A.T.), Herning Hospital, Herning (R.W., D.L., R.M.), Hvidovre Hospital, Hvidovre (L.N., C.A.), Aarhus University Hospital, Aarhus (H.L.N., D.I.), Aalborg University Hospital, Aalborg (B.S.R.), Holbæk Hospital, Holbæk (J.R.M.L.), Kolding Hospital, Kolding (J.S.N.), and Hjørring Hospital, Hjørring (M.K.) - all in Denmark; Karolinska University Hospital, Huddinge, Stockholm (J. Wernerman, I.T., K.K., S.O.-W.), Karolinska University Hospital, Solna (A.O.), and Södersjukhuset, Stockholm (M.B.C.) - all in Sweden; Haukeland University Hospital and University of Bergen, Bergen, Norway (A.B.G., B.S.); Tampere University Hospital, Tampere (S.K.), and Helsinki University Hospital and University of Helsinki, Helsinki (V.P.) - all in Finland; and Liverpool Hospital, Sydney (A.Å.).
Nicolai Haase
Jørn Wetterslev
Jan Wernerman
Anne B Guttormsen
Sari Karlsson
Pär I Johansson
Anders Aneman
Marianne L Vang
Robert Winding
Lars Nebrich
Helle L Nibro
Bodil S Rasmussen
Johnny R M Lauridsen
Jane S Nielsen
Anders Oldner
Ville Pettilä
Maria B Cronhjort
Lasse H Andersen
Ulf G Pedersen
Nanna Reiter
Jørgen Wiis
Jonathan O White
Lene Russell
Klaus J Thornberg
Peter B Hjortrup
Rasmus G Müller
Morten H Møller
Morten Steensen
Inga Tjäder
Kristina Kilsand
Suzanne Odeberg-Wernerman
Brit Sjøbø
Helle Bundgaard
Maria A Thyø
David Lodahl
Rikke Mærkedahl
Carsten Albeck
Dorte Illum
Mary Kruse
Per Winkel
Anders Perner
TRISS Trial Group
Scandinavian Critical Care Trials Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood transfusions are frequently given to patients with septic shock. However, the benefits and harms of different hemoglobin thresholds for transfusion have not been established.

methodsIn this multicenter, parallel-group trial, we randomly assigned patients in the intensive care unit (ICU) who had septic shock and a hemoglobin concentration of 9 g per deciliter or less to receive 1 unit of leukoreduced red cells when the hemoglobin level was 7 g per deciliter or less (lower threshold) or when the level was 9 g per deciliter or less (higher threshold) during the ICU stay. The primary outcome measure was death by 90 days after randomization.

resultsWe analyzed data from 998 of 1005 patients (99.3%) who underwent randomization. The two intervention groups had similar baseline characteristics. In the ICU, the lower-threshold group received a median of 1 unit of blood (interquartile range, 0 to 3) and the higher-threshold group received a median of 4 units (interquartile range, 2 to 7). At 90 days after randomization, 216 of 502 patients (43.0%) assigned to the lower-threshold group, as compared with 223 of 496 (45.0%) assigned to the higher-threshold group, had died (relative risk, 0.94; 95% confidence interval, 0.78 to 1.09; P=0.44). The results were similar in analyses adjusted for risk factors at baseline and in analyses of the per-protocol populations. The numbers of patients who had ischemic events, who had severe adverse reactions, and who required life support were similar in the two intervention groups.

conclusionsAmong patients with septic shock, mortality at 90 days and rates of ischemic events and use of life support were similar among those assigned to blood transfusion at a higher hemoglobin threshold and those assigned to blood transfusion at a lower threshold; the latter group received fewer transfusions. (Funded by the Danish Strategic Research Council and others; TRISS ClinicalTrials.gov number, NCT01485315.).

Indexed as

Erythrocyte TransfusionHemoglobinsAgedFemaleHumansIntensive Care UnitsIschemiaKaplan-Meier EstimateMaleMiddle AgedMyocardial IschemiaRiskShock, SepticSingle-Blind MethodHemoglobins

Identifiers

PMID25270275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.